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1. Introduction 
Vasopressin and the catecholomines have a number 
of similar actions in rat liver. Both activate glycogen- 
olysis [1,2-51 and phosphorylase [2-7,8] and stim- 
ulate gluconeogenesis [3,9-l 11. Although the c&e- 
cholamines increase the hepatic content of adenosine 
3’,5’-cyclic monophosphate (CAMP) (the fl-adrenergic 
response) the stimulation of gly’cogenolysis and gluco- 
neogenesis in rat hepatocytes by adrenaline and nqr- 
adrenaline is mediated mainly by a-receptors, possibly 
via a rise in the [Ca”‘] in the cytoplasm (reviewed 
[ 121). Ca2+ has been implicated also in the actions of 
vasopressin on hepatic glycogenolysis and gluconeog- 
enesis (reviewed [ 131). 
The site of action of the catecholamines and vaso- 
pressin on glycogen metabolism and gluconeogenesis 
is extramitochondrial. In addition, vasopressin has an 
intra-mitochondrial site of action, the increased oxida- 
tion of [ l-‘4C]oleate to 14C02 [ 141. This action of 
vasopressin is Ca2’-dependent. Here we show that the 
catechblamines adrenaline and noradrenaline also 
increase oxidation of [ 1 -‘4C]oleate to 14C02. The 
increased 14C02 production is blocked by the cY-antag- 
onist phentolamine, and is dependent on the presence 
of Ca2+ in the incubation medium. 
2. Materials and methods 
2.1. Reagents 
All enzymes, coenzymes and substrates were 
obtained from BCL, Lewes, East Sussex. Adrenaline 
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was from BDH, Poole, Dorset. Noradrenaline was 
from Winthrop, Surbiton-upon-Thames, Surrey. U. K. 
Phenylephrine was from Boots, Nottingham. Phentol- 
amine mesylate BP (Rogitine) was from CIBA, Hors- 
ham, Sussex. Propranolol-HCl BP (Inderal) was from 
Imperial Chemical Industries, Macclesfield, Cheshire. 
Radiochemicals (including CAMP assay kits) were pur- 
chased from the Radiochemical Centre, Amersham, 
Bucks. 
2.2. Preparation of hepatocytes 
Female Wistar rats (180-250 g) were fed ad 
libitum on standard laboratory diet. They were 
anaesthetized with nembutal(60 mg/kg wt, solution 
in 0.9% NaCl). Isolated hepatocytes were prepared 
essentially as in [ 151 and modified as in [ 161. Prep- 
aration of hepatocytes was commenced between 
0.9:30 and IO:30 h. 
2.3. Experimental procedure 
The incubation procedure and measurements of 
esterification of [ 1 -‘4C]oleate and its conversion to 
14C02 wereasin [17]. Acetoacetate,hydroxybutyrate, 
glucose, pyruvate and lactate were determined in 
neutralized HC104 extracts by enzymic methods 
[ 18-201. The metabolite changes and 14C02 produc- 
tion over 20-60 min were calculated from plots of 
the values at 20,40 and 60 min. CAMP was determined 
in KOH-neutralized HC104-treated hepatocyte extracts 
as in [21], using a kit from the Radiochemical Centre. 
The HC104 extracts were made 4 min after addition 
of the hormones. 
Statistical significance of results was assessed using 
Student’s unpaired t-test except where indicated. 
ElsevierfNorth-Holland Biomedical Press 
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October 1980 
Comparison of the effects of adrenaline and noradrenaline on oxidation of [ l-‘4C]oleate to ‘%O, and CAMP levels in hepatocytes 
from fed rats in the absence or presence of CaCI, 
Addition -CaCl, 
[ 1-‘4C]Oleate 
oxidized to 14C0, 
CAMP content 
(pmol/g fresh wt cells) 
+CaCl, 
[ l-‘4C]Oleate 
oxidized to “‘CO * 
CAMP content 
(pmol/g fresh wt cells) 
None 29.5 ? 1.1 (8) 5.88 f 0.30 (4) 29.5 i 2.4 (8) 5.51 f 0.33 (6) 
Adrenaline (1 pg/ml) 31.9 + 1.1 (6) 10.40 + 1.78 (4)a 42.0 t 1.6 (6)c 8.81 f 0.52 (4)d 
Noradrenaline (1 pg/ml) 32.3 + 1.7 (6) 9.77 k 1.33 (4)a 41.1 f 3.8 (6)b 7.55 * 0.37 (6)c 
a p < 0.05 (paired f-test); b p < 0.05; c p < 0.01; d p < 0.001 
Production of ‘%O, is expressed as nmol . min-’ . g fresh wt cells-’ and the results are mean values ? SEM with no. obs. in 
parentheses. Oleate was 1 mM and CaCI, 2.4 mM when present 
3. Results 
3.1. Effects of adrenaline and noradrenaline on oxi- 
dation of (I-14Cf oleate to 14C02 
The addition of adrenaline (1 pg/ml) and nor- 
adrenaline (1 /_&ml) to hepatocytes from fed rats in 
the presence of Ca*+ (2.4 mM) increased oxidation of 
[ 1 -14C] oleate to 14C02 by 42.4% and 39.3%, respec- 
tively (table 1). The increases were not observed in 
the absence of added Ca*+. In contrast, the catechol- 
amines increased hepatocyte CAMP content in both 
the presence and absence of Ca*+ (table 1). Therefore 
the increases in [ 1 -14C] oleate oxidation to 14C02 are 
not mediated by an increase in CAMP content. Indeed 
dibutyryl-CAMP decreases oxidation of [ 1 -14C]oleate 
to 14C02 in hepatocytes from fed rats [14]. 
The effects of adrenaline and noradrenaline on 
[ 1 -‘4C]oleate oxidation to 14C02 were mimicked by 
phenylephrine (100 Ccg/ml) a synthetic catecholamine 
and a-agonist. Oxidation of [ 1 -‘4C]oleate to 14C02 
was increased by phenylephrine in the presence of 
Ca*+ (control (S), 25.6 f 2.4 nmol . min-’ . g fresh wt 
cells-‘. , plus phenylephrine (5) 35.2 + 3.2 nmol . 
min-’ . g fresh wt cells-‘, p < 0.05) but not in the 
absence of Ca*+ (control (5), 28.5 f 1.9 nmol . 
min -I . g fresh wt cells-‘; plus phenylephrine (5) 
31.8 f 1.9 nmol . min-’ . g fresh wt cells-‘). 
Adrenaline and noradrenaline did not increase 
14C02 production from [ 1 -‘4C]oleate in the presence 
of the a-blocking agent phentolamine (table 2). The 
basal (no hormone) rate of 14C02 production was 
unaffected by phentolamine (not shown). The /3-antag- 
onist propranolol did not diminish the effects of the 
catecholamines on 14C02 production (table 2) and 
rates of 14C02 production were maximal in the 
presence of both propranolol and either adrenaline or 
noradrenaline (table 2). The increased 14C02 produc- 
tion observed on addition of propranolol in the 
presence of either catecholamine (table 2) may in 
part.result from the.propranolol blockade of CAMP 
accumulation in response to the catecholamines (not 
shown). Thus propranolol in the absence of Ca*+ in 
the presence of either catecholamine causes small 
(but not significant) increases in 14C02 production 
(adrenaline alone (4), 32.5 + 0.7 nmol . min-’ . g 
fresh wt-‘; adrenaline + propranolol (4), 38.3 + 3.8 
Table 2 
Effects of phentolamine and propranolol on oxidation of 
[ l-‘4C]oleate to YO, in hepatocytes from fed rats in the 
presence of adrenaline or noradrenaline 
Addition [ l-‘4C]Oleate 
oxidized to 14C0 7. 
None 30.9 f 1.7 (4) 
Adrenaline (1 rg/ml) 43.9 f 1.0 (4)d 
+ phentolamine (30 pg/ml) 31.2 ? 2.0 (4) 
+ propranolol(30 pg/ml) 52.7 + 3.2 (4)d 
None 27.1 k 3.5 (5) 
Noradrenaline (1 fig/ml) 38.6 * 3.4 (5)a 
+ phentolamine (30 pg/ml) 30.6 + 3.6 (5) 
+ propranolol (30 pg/ml) 46.3 ? 4.9 (5)b 
a p < 0.05 (paired f-test); b p < 0.01 (paired I-test); 
c p < 0.05; d p < 0.001; Values significantly different from 
those of the control 
Production of YIO, is expressed as nmol . min-’ . g fresh 
wt cells-’ and the results are mean values f SEM with no. obs. 
in parentheses. Oleate was 1 mM and CaCI, 2.4 mM 
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nmol . min-’ . g fresh wt-‘; noradrenaline alone (5), 
30.8 f 1 .I nmol . min-’ . g fresh wt-‘; noradrenaline t 
propranolol(5) 34.7 f 2.9 nmol . min-’ . g fresh wt-‘). 
Addition of propranolol in the absence of hormone 
also caused variable increases (up to 33%) in 14COs 
production. The reason for this increased 14C02 pro- 
duction is not known. 
3.2. Effects on ketogenesis and glucose production 
Addition of adrenaline or noradrenaline increased 
glucose release to the medium (table 3); this was 
presumably due to activation of glycogenolysis. The 
increased glucose release was observed both in the 
presence and absence of added Ca2+, which suggests 
that in the absence of Ca2+ glycogenolysis was 
mediated by the increased CAMP concentrations (see 
table 1). In support of this, catecholamine-stimulated 
glucose release in the absence of Ca2+ was diminished 
on addition of propranolol (not shown). Production 
of lactate and pyruvate was slightly inhibited by 
adrenaline and noradrenaline (table 3). The catechol- 
amines were without effect on the rate of ketogenesis 
from oleate in either the presence or absence of Ca2+ 
(table 3). Catecholamine-induced increases in glucose 
release (table 3) and 14C02 production from [ 1 -14C]- 
oleate were observed in the same experiments show- 
ing that the cells were responsive to the hormones. 
4. Discussion 
We have shown that vasopressin stimulates 14C02 
production from [ l- 14C]oleate in a Ca2+-dependent 
manner [ 141. These results demonstrate that adren- 
aline and noradrenaline similarly stimulate r4C02 
production from [ 1 -14C] oleate by an a-adrenergic, 
CAMP-independent mechanism. 
As [ 1 -‘4C]oleate is metabolized to [ 1 -14C] acetyl 
CoA increased production of 14C02 from [ 1-‘4C]- 
oleate could result from increased tricarboxylic acid 
flux. Supporting this, stimulation of a-receptors 
markedly increases 02-consumption by the perfused 
rat liver [22]. The Ca2+ requirement for a-adrenergic 
stimulation of 14C02 production from [ 1 -14C] oleate 
implies that a change in mitochondrial Ca2+ uptake 
may be involved in the mechanism. Perfusion of rat 
liver with cr-adrenergic agonists does induce a stable 
modification of the mitochondria which leads to 
increased Ca2+ uptake and retention [23]. As enzymes 
of the tricarboxylic acid cycle, NAD isocitrate 
dehydrogenase (EC 1 .l .1.4.1) and the 2-oxoglutarate 
dehydrogenase complex, are activated by low [Ca”‘] 
[24,25] it is tempting to speculate that the catechol- 
amines exert their effects on [ 1 -14C]oleate oxidation 
to 14C02 by activating these enzymes via an increase 
in mitochondrial Ca’+. Alternatively the increased 
14C02 production may be secondary to stimulated 
respiratory chain activity. Mitochondria prepared 
from hepatocytes (from starved rats) treated with 
catecholamines show increased rates of ADP-depen- 
dent respiration and mitochondrial ATPase activity, 
and these effects are o-mediated [26-281. 
The lack of effect of the catecholamines on 
ketogenesis from oleate (table 3) is in marked contrast 
to the decreased ketogenesis from oleate observed in 
the presence of vasopressin [ 14,291. In this case the 
increased oxidation of oleate to CO2 contributes to 
the antiketogenic effect of the hormone [ 141. How- 
ever, it should be noted that part of the antiketogenic 
action of vasopressin may be related to increased 
glycolytic flux [ 14,291 whereas adrenaline and nor- 
adrenaline tend to decrease output of lactate and 
pyruvate (table 3). The interpretation of the results 
obtained with the catecholamines is made difficult 
by the increases in CAMP content that occur conco- 
mitantly with the a-response (table 1). These increases 
in CAMP content might be expected to increase 
ketogenesis as glucagon and dibutyryl CAMP increase 
ketogenesis [29-311. However the increases in CAMP 
elicited by the catecholamines are much smaller 
(5- 1 O-times smaller) than those elicited by glucagon 
(unpublished, [32]). Small stimulatory effects of 
adrenaline on ketone body production by perfused 
livers of fed rats have been observed in [33,34]. 
It is not known to what extent the effects of the 
catecholamines on 14C02 production from [ 1 -14C] -
oleate may be secondary to changes in the rate of 
removal of [ 1 -‘4C]oleate from the medium or the 
rate of entry of oleoyl-CoA into the mitochondria. It 
is unlikely that the increased 14C02 production is 
secondary to increased extraction of free fatty acid 
since both adrenaline and noradrenaline decreased 
the extraction of free fatty acids by the perfused rat 
liver [33]. However it is possible that the catechol- 
amines may change the rate of entry of long-chain 
fatty acyl CoA into the mitochondria. Adrenaline 
inhibits acetyl-CoA carboxylase (EC 6.4.12) in the 
perfused rat liver [35] and we have found that nor- 
adrenaline (1 pg/ml) also inhibits acetyl-CoA car- 
boxylase activity (assayed both with and without 
83 
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preincubation with potassium citrate to activate the 
enzyme) in extracts of rat hepatocytes (unpublished). 
Such inhibition of acetyl-CoA carboxylase could 
decrease the concentration of malonyl-CoA, an 
inhibitor of entry of long-chain fatty acyl-CoA into 
the mitochondria [36,37]. However, we found no 
effect of adrenaline or noradrenaline on ketogenesis 
from oleate either in the presence or absence of Ca2+ 
(table 3) which might imply that if the rate of keto- 
genesis is governed solely by the mitochondrial 
uptake of free fatty acid [36,37] the Ca2+-dependent 
activation by the catecholamines of 14C02 produc- 
tion from [ 1 -‘4C]oleate is not secondary to an increase 
in the mitochondrial uptake of fatty acyl CoA by 
this mechanism. 
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